| abstract |
The present invention concerns novel compounds of the general formula: (I) wherein R1 is halogen or hydrogen and R2 is halogen; X is either oxygen, sulfor or methylene R3 and R4 are the same or different and selected from hydrogen and lower alkyl; n is 2 or 3; A is selected from the following pyrimidyl or pyridyl groups wherein R5 is selected from hydrogen, lower alkyl or halogen; R6 and R7 are the same or different and selec-ted from hydrogen, halogen, lower alkyl, electron donor groups such as lower alkoxy or hydroxy, electron accep-tor groups such as cyano, nitro, trifluoromethyl, COOR8, CONR9R10 or CO-B; wherein R8 is hydrogen or lower alkyl; R9 and R10 are the same or different and selected from hydrogen, lower alkyl and cycloalkyl; B is selected from wherein m is 1, 2, 3 or 4. R11 is selected from hydrogen or lower alkyl, and the pharmacologically active salts thereof. The new compounds are useful for treating mental disorders. |